Efficacy and Safety of Viusid and Asbrip in Hospitalized Patients With Mild and Moderate COVID-19

Clinical trial NCT04701502 · COMPLETED

Trial details

NCT number: NCT04701502
Sponsor: Catalysis SL
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Covid19 Respiratory Disease Immune System Immunomodulator Antiseptic Supportive Care

Start date: 2020-11-09
Primary completion: 2021-02-15
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.